Stevanato Group S P A Quick Ratio (STVN) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Stevanato Group S p a   (NYSE: STVN)

Stevanato Group S P A 's Quick Ratio

STVN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the fourth quarter 2025, Quick Ratio deteriorated to 0.24 below Stevanato Group S P A 's average Quick Ratio.

Within Medical Equipment & Supplies industry 94 other companies have achieved higher Quick Ratio than Stevanato Group S P A in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from 0 to 1945.

Explain Quick Ratio?
How much Cash & cash equivalents STVN´s has?
What are STVN´s Current Liabilities?




STVN Quick Ratio (Dec 31 2025)
Q4
0
Q3
0
Q2
0
Q1
(Dec 31 2024)
Q4
Y / Y Current Liabilities Change 12.23 % 12.23 % 12.23 % 12.23 % -16.87 %
Y / Y Cash & cash equivalent Change 32.9 % 32.9 % 32.9 % 32.9 % 41.19 %
Quick Ratio MRQ 0.24 0.24 0.24 0.24 0.21
STVN's Total Ranking # 1945 # 0 # # #
Seq. Current Liabilities Change 0 % 0 % 0 % 12.23 % 0 %
Seq. Cash & cash equivalent Change 0 % 0 % 0 % 32.9 % 0 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 95
Healthcare Sector # 424
Overall Market # 1945


Quick Ratio Statistics
High Average Low
0.49 0.27 0.12
(Dec 31 2022)   (Dec 31 2023)




Financial Statements
Stevanato Group S P A 's Current Liabilities $ 600 Millions Visit STVN's Balance sheet
Stevanato Group S P A 's Cash & cash equivalent $ 146 Millions Visit STVN's Balance sheet
Source of STVN's Sales Visit STVN's Sales by Geography


Cumulative Stevanato Group S P A 's Quick Ratio

STVN's Quick Ratio for the trailling 12 Months

STVN Quick Ratio

(Dec 31 2025)
12 Months
0
12 Months
0
12 Months
0
12 Months
(Dec 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth 12.23 % 3.9 % -3.66 % -10.56 % -16.87 %
Y / Y Cash & cash equivalent TTM Growth 32.9 % 34.48 % 36.34 % 38.54 % 41.19 %
Quick Ratio TTM 0.24 0.24 0.23 0.22 0.21
Total Ranking TTM # 2987 # 0 # # #
Seq. Current Liabilities TTM Growth 2.8 % 2.88 % 2.97 % 3.06 % -4.83 %
Seq. Cash & cash equivalent TTM Growth 6.6 % 7.06 % 7.6 % 8.23 % 7.87 %


On the trailing twelve months basis In Spite of the unchanged in Current Liabilities in the Q4 2025 to $600.18 millions, cumulative Quick Ratio remained unchanged at 0.24 below the Stevanato Group S P A average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 166 other companies have achieved higher Quick Ratio than Stevanato Group S P A . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from 0 to 2987.

Explain Quick Ratio?
How much Cash & cash equivalents STVN´s has?
What are STVN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 167
Healthcare Sector # 778
Within the Market # 2987


trailing twelve months Quick Ratio Statistics
High Average Low
0.49 0.31 0.12
(Dec 31 2022)   (Dec 31 2023)




Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Medical Equipment & Supplies Industry Quick RatioDec 31 2025 MRQ Cash & cash equivalentDec 31 2025 MRQ Current Liabilities
Baxter International Inc   0.66 $ 1,966.000  Millions$ 2,970.000  Millions
Cytosorbents Corporation  0.64 $ 6.249  Millions$ 9.709  Millions
Innovage Holding Corp   0.64 $ 105.904  Millions$ 164.807  Millions
Artivion Inc   0.64 $ 64.908  Millions$ 101.556  Millions
Avita Medical Inc   0.62 $ 39.142  Millions$ 62.677  Millions
Pro dex Inc   0.62 $ 7.159  Millions$ 11.520  Millions
Nyxoah Sa  0.61 $ 33.601  Millions$ 54.833  Millions
Lensar Inc   0.61 $ 17.978  Millions$ 29.348  Millions
Stereotaxis Inc   0.60 $ 13.421  Millions$ 22.360  Millions
Integra Lifesciences Holdings Corp  0.58 $ 263.741  Millions$ 455.981  Millions
Avanos Medical Inc   0.57 $ 89.800  Millions$ 157.000  Millions
Msa Safety Inc  0.57 $ 165.067  Millions$ 289.211  Millions
Anteris Technologies Global Corp   0.57 $ 6.697  Millions$ 11.822  Millions
Solventum Corporation  0.56 $ 878.000  Millions$ 1,563.000  Millions
Align Technology inc   0.55 $ 1,094.908  Millions$ 2,005.558  Millions
U S Physical Therapy Inc  0.53 $ 35.570  Millions$ 66.654  Millions
Haemonetics Corporation  0.53 $ 306.763  Millions$ 578.113  Millions
Teleflex Incorporated  0.50 $ 378.564  Millions$ 762.026  Millions
Interpace Biosciences Inc   0.49 $ 2.505  Millions$ 5.103  Millions
Sanuwave Health Inc   0.45 $ 11.959  Millions$ 26.652  Millions
Orthofix Medical Inc   0.44 $ 82.025  Millions$ 186.329  Millions
Dexcom Inc   0.43 $ 917.700  Millions$ 2,129.800  Millions
Nuo Therapeutics Inc   0.42 $ 0.549  Millions$ 1.306  Millions
Iridex Corp  0.41 $ 6.028  Millions$ 14.608  Millions
Nuwellis Inc   0.40 $ 1.085  Millions$ 2.686  Millions
Picard Medical Inc   0.40 $ 7.451  Millions$ 18.695  Millions
Alcon inc   0.37 $ 1,547.000  Millions$ 4,162.000  Millions
Masimo Corp  0.37 $ 152.300  Millions$ 411.000  Millions
Boston Scientific Corporation  0.36 $ 1,965.000  Millions$ 5,439.000  Millions
Vsee Health Inc   0.35 $ 5.266  Millions$ 15.056  Millions

Date modified: 2026-07-07T13:27:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.